RA CAPITAL MANAGEMENT, L.P. Diversified Active

CIK: 0001346824 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value ($000): $815,257 (100.0% shares, 0.0% debt)

Holdings (24)

WVE WAVE LIFE SCIENCES LTD 23.9%
Value ($000) $194,938 Shares 7,088,651 Est. Cost $15.68 Unrealized +78.1%
ASND ASCENDIS PHARMA A S 18.6%
Value ($000) $151,480 Shares 5,409,990 Est. Cost $17.65 Unrealized
AVEXIS INC 15.2%
Value ($000) $123,565 Shares 1,625,211 Est. Cost $31.86 Unrealized
ACHILLION PHARMACEUTICALS INC 7.0%
Value ($000) $57,396 Shares 13,633,220 Est. Cost $6.18 Unrealized
AQUINOX PHARMACEUTICALS INC 4.4%
Value ($000) $36,190 Shares 2,184,047 Est. Cost $13.67 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 3.6%
Value ($000) $29,314 Shares 3,489,795 Est. Cost $9.20 Unrealized -24.4%
RA PHARMACEUTICALS INC 3.5%
Value ($000) $28,780 Shares 1,351,808 Est. Cost $15.19 Unrealized
MYOVANT SCIENCES LTD 3.4%
Value ($000) $27,570 Shares 2,348,422 Est. Cost $12.19 Unrealized
ZOGENIX INC 3.3%
Value ($000) $26,596 Shares 2,451,237 Est. Cost $13.32 Unrealized
ESPR ESPERION THERAPEUTICS INC 3.1%
Value ($000) $24,883 Shares 704,701 Est. Cost $22.90 Unrealized 0.0%
LOXO ONCOLOGY INC 1.5%
Value ($000) $12,579 Shares 298,935 Est. Cost $42.08 Unrealized
ARDX ARDELYX INC 1.3%
Value ($000) $10,478 Shares 828,283 Est. Cost $10.51 Unrealized +25.2%
ACORDA THERAPEUTICS INC 1.3%
Value ($000) $10,286 Shares 489,828 Est. Cost $21.00 Unrealized
AUDENTES THERAPEUTICS INC 1.1%
Value ($000) $9,073 Shares 532,426 Est. Cost $17.81 Unrealized
FOAMIX PHARMACEUTICALS LTD 1.1%
Value ($000) $9,010 Shares 1,820,138 Est. Cost $9.26 Unrealized
IGNYTA INC 1.1%
Value ($000) $8,818 Shares 1,025,291 Est. Cost $8.60 Unrealized
ONC BEIGENE LTD 1.1%
Value ($000) $8,786 Shares 240,000 Est. Cost $29.62 Unrealized
CALITHERA BIOSCIENCES INC 1.0%
Value ($000) $8,374 Shares 725,000 Est. Cost $11.55 Unrealized
DICERNA PHARMACEUTICALS INC 1.0%
Value ($000) $8,257 Shares 2,428,571 Est. Cost $28.25 Unrealized
TGTX TG THERAPEUTICS INC 1.0%
Value ($000) $8,155 Shares 700,000 Est. Cost $10.06 Unrealized -28.6%
PTGX PROTAGONIST THERAPEUTICS INC 1.0%
Value ($000) $8,150 Shares 636,248 Est. Cost $13.67 Unrealized +17.9%
KALV KALVISTA PHARMACEUTICALS INC 0.6%
Value ($000) $4,616 Shares 591,070 Est. Cost $7.37 Unrealized +1.9%
EIGER BIOPHARMACEUTICALS INC 0.5%
Value ($000) $4,056 Shares 354,200 Est. Cost $16.17 Unrealized
MEDICINES CO 0.5%
Value ($000) $3,907 Shares 79,899 Est. Cost $33.94 Unrealized